Vivli Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Vivli's estimated annual revenue is currently $1.1M per year.(i)
  • Vivli's estimated revenue per employee is $61,200

Employee Data

  • Vivli has 18 Employees.(i)
  • Vivli grew their employee count by 6% last year.

Vivli's People

NameTitleEmail/Phone
1
CEO, Vivli, Center for Global Data ResearchReveal Email/Phone
2
Director Technical OperationsReveal Email/Phone
3
Senior Clinical Research ManagerReveal Email/Phone
4
Clinical Data ManagerReveal Email/Phone
5
Senior Statistical AdvisorReveal Email/Phone
6
Project CoordinatorReveal Email/Phone
7
Technical Operations EngineerReveal Email/Phone
8
Principal Software EngineerReveal Email/Phone
9
Senior Software ArchitectReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1M176%N/AN/A
#2
$13.4M13110%N/AN/A
#3
$42.8M3360%N/AN/A
#4
$7.8M760%N/AN/A
#5
$8.2M803%N/AN/A
#6
$0.1M6-25%$1.9MN/A
#7
$5.7M6211%N/AN/A
#8
$0.9M140%N/AN/A
#9
$25.2M2257%N/AN/A
#10
$6.3M7113%$1.7MN/A
Add Company

What Is Vivli?

Vivli – Global Clinical Trials Data Sharing Platform Our mission: Promote, coordinate, and facilitate clinical research data sharing through the creation and implementation of a sustainable global data-sharing enterprise.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$1.1M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vivli News

2022-04-19 - Efficacy of once-weekly tirzepatide versus once-daily insulin ...

For details on submitting a request, see the instructions provided at http://www.vivli.org. Declaration of interests. TB has received honoraria...

2022-02-22 - NIH Initiative Seeks to Improve Access to NIH-Funded Data

The six GREI repositories are: • Dryad • Dataverse • Figshare • Mendeley Data • Open Science Framework • Vivli...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.1M18-10%$161M
#2
$3.5M18N/AN/A
#3
$1.6M18N/AN/A
#4
$2.5M18-14%N/A
#5
$3.5M18-40%N/A